EAPC2016: Abstracts

doi:10.1177/0269216316646056

Cited by 18 publications

(5 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Furthermore, whilst 79% of this group stated they were already confident in discussing death and bereavement, 42% agreed that their confidence increased as a result of workshop participation. These findings appear particularly pertinent considering the research described above regarding students' feeling ill-equipped to discuss death with dying patients [54].…”

Section: Discussionmentioning

confidence: 80%

Archaeology and contemporary death: Using the past to provoke, challenge and engage

et al. 2020

View full text Add to dashboard Cite

While death is universal, reactions to death and ways of dealing with the dead body are hugely diverse, and archaeological research reveals numerous ways of dealing with the dead through time and across the world. In this paper, findings are presented which not only demonstrate the power of archaeology to promote and aid discussion around this difficult and challenging topic, but also how our approach resulted in personal growth and professional development impacts for participants. In this interdisciplinary pilot study, archaeological case studies were used in 31 structured workshops with 187 participants from health and social care backgrounds in the UK, to explore their reactions to a diverse range of materials which documented wide and varied approaches to death and the dead. Our study supports the hypothesis that the past is a powerful instigator of conversation around challenging aspects of death, and after death care and practices: 93% of participants agreed with this. That exposure to archaeological case studies and artefacts stimulates multifaceted discourse, some of it difficult, is a theme that also emerges in our data from pre, post and follow-up questionnaires, and semi-structured interviews. The material prompted participants to reflect on their biases, expectations and norms around both treatment of the dead, and of bereavement, impacting on their values, attitudes and beliefs. Moreover, 87% of participants believed the workshop would have a personal effect through thinking differently about death and bereavement, and 57% thought it would impact on how they approached death and bereavement in their professional practice. This has huge implications today, where talk of death remains troublesome, and for some, has a near-taboo status–‘taboo’ being a theme evident in some participants’ own words. The findings have an important role to play in facilitating and normalising discussions around dying and bereavement and in equipping professionals in their work with people with advanced illness.

show abstract

Section: Discussionmentioning

confidence: 80%

Archaeology and contemporary death: Using the past to provoke, challenge and engage

et al. 2020

View full text Add to dashboard Cite

show abstract

“…The 67 citations were eliminated from this review since twenty-six were not published, [ 40 - 65 ] eleven did not recruit subjects [ 66 - 76 ] three were terminated [ 77 - 79 ], four were withdrawn [ 80 - 83 ] one was suspended [ 84 ] fourteen were recruiting [ 85 - 98 ] two studies were open-label trials, [ 99 , 100 ] four were observational studies, [ 101 - 104 ] one study was a retrospective study [ 105 ], and one study evaluated dexmedetomidine plus melatonin [ 106 ]. As a result, 44 citations of 25 studies were included for qualitative synthesis in this review [ 15 - 20 , 30 , 41 , 107 - 119 ]. However, only 24 studies could be included for quantitative synthesis [ 15 - 30 , 113 , 120 - 124 ].…”

Section: Resultsmentioning

confidence: 99%

“…Unfortunately, the outcomes have varied across studies. Although a previous review displayed the effectiveness of melatonin agonists for preventing delirium [ 31 ], the review did not include some studies [ 16 , 20 - 23 , 26 ] . Additionally, several recent studies have been published [ 27 - 29 ].…”

Section: Introductionmentioning

confidence: 99%

Melatonin Receptor Agonists for the Prevention of Delirium: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

Maneeton

Kongsaengdao

Maneeton

et al. 2022

View full text Add to dashboard Cite

Background: Although a previous review illustrated the efficacy of melatonin receptor agonists (MRAs) in preventing delirium, some recent randomized controlled trials (RCTs) did not confirm these effects. Objectives: This study systematically reviewed the efficacy, acceptability, and tolerability of MRAs for delirium prevention. Materials and Methods: We searched electronic databases, including Scopus, PubMed, CINAHL, and Controlled Trials Register, from their inception to February 20, 2022. The primary efficacy outcome was delirium incidence rate after MRA administration; relative risks (RRs), overall discontinuation, and discontinuation due to adverse events are also presented. Results: The overall pooled incidence rates of delirium in MRA-treated and placebo-treated groups were significantly different with RR (95% CI)=0.66(0.52, 0.84, ), I2=59%. Similarly, the incidence rate was significantly lower in the melatonin-treated group than in the placebo-treated group [RR (95% CI) =0.65 (0.49, 0.88), I2=65%]. Unfortunately, incidence rates were not significantly different between ramelteon-treated and placebo-treated groups [RR (95% CI) =0.67 (0.42, 1.08), I2=50%]. The pooled incidence rate of delirium of either Melatonin- or Ramelteon--the treated group was not significantly different from the placebo-treated group in elderly patients. The pooled incidence rate of delirium was significantly lower in the melatonin-treated group than in the benzodiazepine-treated group. Conclusion: Based on this review, Melatonin, could prevent delirium with a small effect size. However, Ramelteon did not show efficacy in preventing delirium. Additionally, either Melatonin or Ramelteon individually, did not show effectiveness in preventing delirium in elderly patients. Therefore, using MRAs to prevent delirium in clinical practice should be cautious. However, future well-defined and large sample size studies could verify these findings.

show abstract

“…36 47 A number of authors have pointed out a need for systematic research and guidance on the process of withdrawing ventilation. [48][49][50][51][52] They describe emotional, practical and also ethical challenges, [53][54][55][56] especially in distinguishing euthanasia 11 30 31 57-60 from a termination of ventilation as "letting die". 61 This can result in not respecting the patient's wish for discontinuation.…”

Section: Refusing and Withdrawing Life-sustaining Treatmentmentioning

confidence: 99%

The wish to die and hastening death in amyotrophic lateral sclerosis: A scoping review

Erdmann

Spoden

Hirschberg

et al. 2021

BMJ Support Palliat Care

View full text Add to dashboard Cite

BackgroundAmyotrophic lateral sclerosis (ALS) develops into a life-threatening condition 2 to 4 years after the onset of symptoms. Although many people with the disease decide in favour of life-sustaining measures, thoughts about hastening death are not uncommon.ObjectivesOur aim was to examine the scope of literature on the wish to die in ALS and provide an insight into determinants and motives for different end-of-life options.MethodsWe searched eight databases for English and German publications on death wishes in ALS for the period from 2008 to 2018 and updated the search up to May 2020. After the screening process, 213 full texts were included for the final analysis. We analysed the texts in MAXQDA, using deductively and inductively generated codes.ResultsWe identified end-of-life considerations, ranging from wishes to die without hastening death, to options with the possibility or intention of hastening death. Besides physical impairment, especially psychosocial factors, socio-demographic status and socio-cultural context have a great impact on decisions for life-shortening options. There is huge variation in the motives and determinants for end-of-life considerations between individuals, different societies, healthcare and legal systems.ConclusionsFor a variety of reasons, the information and counselling provided on different options for sustaining life or hastening death is often incomplete and insufficient. Since the motives and determinants for the wish to hasten death are extremely diverse, healthcare professionals should investigate the reasons, meaning and strength of the desire to die to detect unmet needs and examine which interventions are appropriate in each individual case.

show abstract

EAPC2016: Abstracts

Cited by 18 publications

References 36 publications

Archaeology and contemporary death: Using the past to provoke, challenge and engage

Archaeology and contemporary death: Using the past to provoke, challenge and engage

Melatonin Receptor Agonists for the Prevention of Delirium: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

The wish to die and hastening death in amyotrophic lateral sclerosis: A scoping review

Contact Info

Product

Resources

About